Having difficulties with your experiment?
We are dedicated to your success. Get back on track. View our expert recommendations for commonly encountered problem scenarios.
View the relevant questions below:
Beginning your experiment?
Visit our
Adenoviral Expression
Here are possible causes and solutions:
Cause | Solution |
Incorrect antibiotic used to select for transformants | Select for transformants on LB agar plates containing 100 μg/mL ampicillin. |
LR recombination reaction not treated with proteinase K | Treat reaction with proteinase K before transformation. |
Too much entry clone DNA used in the LR reaction | Use 50–150 ng of the entry clone in the LR reaction. |
Inappropriate ratio of entry clone:DEST vector used in the LR reaction | Aim for a 1:1 molar ratio of entry clone:DEST vector. |
LR recombination of >5 kb insert only incubated for 1 hr | For inserts larger than 5 kb, we recommend to incubate the LR reaction overnight. Note: This overnight incubation will also boost colony count for smaller inserts. |
Adenoviral Destination vector DNA was sheared | Use care when handling the adenoviral Destination vector. Do not perform excessive manipulations (e.g.,vortexing or pipetting the solution vigorously) that may shear the DNA. |
Didn’t use the suggested amount of LR Clonase® II enzyme mix or LR Clonase® II enzyme mix was inactive | -Make sure to store the LR Clonase® II enzyme mix at –20°C. |
Not enough LR reaction transformed | Transform 2–3 μL of the LR reaction into the appropriate competent E. coli strain. Use E. coli cells with a transformation efficiency >1 x 108 cfu/μg. |
Not enough transformation mixture plated | Increase the amount of E. coli plated. |
Here are possible causes and solutions:
Cause | Solution |
LR reaction transformed into an E. coli strain containing the F′ episome and the ccdA gene | Use an E. coli strain that does not contain the |
Deletions (full or partial) of the ccdB gene from adenoviral Destination vector | The adenoviral Destination vectors are provided in solution and are ready to use in an LR reaction. However, if you wish to propagate them, we recommend using One Shot® ccdB Survival™ 2 T1R Chemically Competent Cells (Cat. No. A10460). |
Here are possible causes and solutions:
Cause | Solution |
Low transfection efficiency: | -Use care when handling the adenoviral Destination vector. Do not perform excessive manipulations (e.g.,vortexing or pipetting the solution vigorously) that may shear the DNA. |
Viral supernatant too dilute | Concentrate virus using CsCl purification or any method of choice. |
Viral supernatant frozen and thawed multiple times | Do notfreeze/thaw viral supernatant more than 10 times. |
Gene of interest is large | Viral titers generally decrease as the size of the insert increases; inserts larger than 6 kb (for pAd/CMV/V5-DEST™) and 7.5 kb (for pAd/PL-DEST™) are not recommended. |
Gene of interest is toxic to cells | Generation of constructs containing activated oncogenes or potentially harmful genes is not recommended. |
Here are possible causes and solutions:
Cause | Solution |
Viral stocks stored incorrectly | Aliquot and store stocks at –80°C. Do not freeze/thaw more than 10 times. |
Incorrect titering of cell line used | Use the 293A cell line or any cell line with the characteristics discussed on page 23 of the manual. |
Agarose overlay incorrectly prepared | Make sure that the agarose is not too hot before addition to the cells; hot agarose will kill the cells. |
Viral stock with very low titer or very high titer | Titer adenovirus using a wider range of 10-fold serial dilutions (e.g.,10-2 to 10-8). |
This could be due to insufficient dilution of the viral supernatant. We recommend tittering the adenovirus stock using 10-fold serial dilutions ranging from 10-4 to 10-9.
Here are possible causes and solutions:
Cause | Solution |
Viral stocks stored incorrectly | Aliquot and store stocks at –80°C. Do not freeze/thaw more than 10 times. |
Gene of interest contains a Pac I site | Perform mutagenesis to change or remove the PacI site. |
Here are possible causes and solutions:
Cause | Solution |
Poor transduction efficiency: |
-Make sure that your cells are healthy before transduction. |
MOI too low | Transduce your adenoviral construct into cells using a higher MOI. |
Low viral titer | Amplify the adenoviral stock using the procedure on page 20 of the manual. |
Adenoviral stock contaminated with RCA (replication-competent adenovirus) | -Screen for RCA contamination. |
Cells harvested too soon after transduction | Do not harvest cells until at least 24 hours after transduction. |
Cells harvested too long after transduction | For actively dividing cells, assay for maximal levels of recombinant protein expression within 5 days of transduction. |
Gene of interest is toxic to cells | Generation of constructs containing activated oncogenes or potentially harmful genes is not recommended. |
Here are possible causes and solutions:
Cause | Solution |
Too much crude viral stock used | -Reduce the amount of crude viral stock used for transduction ordilute the crude viral stock. |
Wild-type RCA (replication-competent adenovirus) contamination | Screen for RCA contamination. Plaque purify to isolate recombinant adenovirus or prepare a new adenoviral stock. |
Gene of interest is toxic to cells | Generation of constructs containing activated oncogenes or potentially harmful genes is not recommended. |
For Research Use Only. Not for use in diagnostic procedures.